T cells are central to adaptive immune response against T. cruzi infection. In the chronic stage of Chagas disease, circulating parasite-specific memory T cells show reduced functionality and increased expression of inhibitory receptors, possibly as a result of persistent antigenic stimulation. This exhausted phenotype has been linked to progression of cardiac pathology while, contrariwise, the presence of polyfunctional T cells shows association with therapeutic success and more efficient control of infection.
Introduction 1
Chronic infections are one of the circumstances under which T cells encounter the 2 challenge of appropriately regulating the immune response in persistent presence of 3 antigenic stimulus. In such settings, a process known as T cell exhaustion takes place, 4 by which these cells acquire features believed to hamper sterile immunity, such as 5 hierarchical loss of effector functions, altered gene expression regulation and metabolic 6 disarrangements [1] [2] [3] . The increased and/or sustained expression of inhibitory receptors 7 on the cellular surface of T cells is another of these characteristics, and is often regarded 8 as the hallmark of cell exhaustion 3,4 . 9 In chronic infection with Trypanosoma cruzi, i.e. chronic Chagas disease, evidence of 10 exhausted T cells in circulation has accumulated during the last decades 5 . In fact, the 11 frequency of cells with reduced effector capabilities has been directly correlated to 12 cardiac compromise 6, 7 . The association of therapeutic success of benznidazole with a 13 reduction of T cells with an exhausted profile in the circulation of treated subjects 8,9 and 14 the observation of a richer response profile in serodiscordant subjects 10 further support 15 the relevance of persistent antigen-specific activation for ineffective adaptive immunity 16 against the parasite. 17
Although PD-1 and CTLA-4 were the pioneer inhibitory receptors to be studied in relation 18 to T cell exhaustion, other molecules were demonstrated to complement their function in 19 a lower hierarchical level, apparently enabling the fine-tuning of T cell inhibition 2,4,11 . 20 Among these molecules, TIGIT, Tim-3 and Lag-3 have been found to be implicated in 21 chronic viral infections, and arise as promising targets for immune-enhancing 22 therapies 4, 11 . Their role in chronic Chagas disease is yet to be investigated. 23
The study of inhibitory receptors and their relationship with T cell exhaustion requires the 24 analysis of T cell activation upon antigen specific stimulation, but the heterogeneity of 25 response profiles displayed by the CD4 + T cell subset is a hurdle to the measurement of 26 overall activation. This has been addressed by several research groups, resulting in the 27 development of flow cytometry techniques based on the detection of molecules, globally 28 referred to as activation induced markers (AIM) [12] [13] [14] . Here, we take advantage of this 29 methodology to characterize the expression of TIGIT, Tim-3 and Lag-3 in peripheral 30 blood CD4 + T cells from chronic Chagas disease patients and their relation to T. cruzi-31 specific and non-antigen-specific activation.
Donors, materials and methods 33

Subjects inclusion and blood sample collection 34
Blood samples were collected from non-infected donors and patients with chronic 35
Chagas disease after the nature of this study was explained to them and written consent 36 was given, in accordance with the guidelines of the protocol approved by the Medical 37 Ethics Committee of the and the Hospital General de Agudos "Dr.Ignacio Pirovano" and 38 the Instituto Nacional de Parasitologia "Dr.M.Fatala Chaben". The sample collection 39 protocol followed the tenets of the declaration of Helsinki. All subjects were of age at the 40 time of sample collection. The study population included 20 patients with chronic Chagas 41 disease with at least 2 reactive serological tests, who were categorized, according to 42
Kuschnir's classification 15 into groups A (without demonstrable cardiac pathology, 43
Kuschnir class 0, n=10) or C (with signs of cardiac alterations, Kuschnir class 1 or 2, 44 n=10). Ten donors were included as well, with negative serology for T. cruzi infection. 45
Samples consisted in 35 to 50 ml peripheral venous blood, collected in EDTA anti-46 coagulated tubes and processed up to 4 h after collection. Peripheral blood mononuclear 47 cells (PBMC) were isolated by centrifugation (400 ×g, room temperature, 40 min) in a 48
Ficoll-Paque gradient medium (GE Healthcare Bio-Sciences, Uppsala, Sweden), 49 quantified by manual count in Neubauer chamber, and aliquoted in fetal bovine serum 50 (FBS; Natocor, Córdoba, Argentina) with 10% v/v DMSO to be cryopreserved in liquid 51 nitrogen until used. 52
Parasite lysate 53
T. cruzi trypomastigote/amastigote lysate was prepared from VERO cells infected with 54 Sylvio strain (Discrete Typing Unit TcI 16 ) parasites (MOI 3:1) supernatants, as described 55 elsewhere 17 . After lysis, the suspension was filter-sterilized through a 0.2 µm pore-size 56 membrane, aliquoted, and stored at -80 °C until use. 57
Cell culture and stimulation 58
For antigen stimulation, 3×10 6 PBMC from each subject were seeded in 6 wells from a 59 96-well U-bottom plates and cultured in assay medium alone or with 10 µg/ml T. cruzi 60 lysate, or 5 µg/ml phytohaemagglutinin (PHA, Sigma, St Louis, MO, USA). Cells were 61 incubated at 37°C in a humidified, 5% CO2 atmosphere for 18h. 62
Flow cytometry analysis of T cells 63
After culture, cells were centrifuged at 400 ×g for 10 min at room temperature (RT) and 64 supernatants were discarded. Next, they were washed with PBS by centrifugation at 700 65 ×g during 3 min at RT, transferred into a 96-well V-bottom plate and resuspended in 25 66 µl of staining solution, containing the antibodies detailed in Table 1 , diluted in 1X 67 live/dead fixable viability dye (Zombie-Aqua, Biolegend, San Diego, CA, USA). After 68 staining for 30 min at RT, cells were washed with PBS, fixed with Fixation Buffer 69 (Biolegend) for 20 min at RT in the dark and washed with PBS. Isotype control stained 70 samples were used to set the cut point values for each marker. A minimum of 5×10 5 71 events within the lymphocyte population were acquired in a FACSCanto II (BD 72 Biosciences, San Diego, CA, USA) flow cytometer using FACS Diva Software (BD 73 Biosciences). Flow cytometry analysis was carried out with the program FlowJo (FlowJo 74 LLC, Ashland, OR, USA). All antibodies were used at optimal concentrations determined 75 by previous titration experiments. 76 
Results 88
Ox40 and CD25 are useful as activation markers in T. cruzi specific CD4+ T cell 89 response 90
Seeking to determine whether the AIM assay proposed by Reiss et al. 13 is useful for the 91 measurement of CD4 + T cell activation against T. cruzi antigens, PBMC from non-92 infected individuals (group NI), and chronic Chagas disease patients with (group C) and 93 without (group A) cardiac compromise were stimulated in vitro with parasite lysate to 94 evaluate pathogen-specific response, and with PHA to assess overall, non-specific 95 activation. Cells were stained and analyzed by flow cytometry. The gating strategy used 96 for this analysis is represented in Figure 1A and B. 97
As shown in Figure 1C -E, while the frequency of activated cells was similar between 98 groups both upon non-antigen specific stimulation with PHA (p=0.9) or without 99 stimulation (p=0.5), statistically significant differences were observed in the frequency of 100 Ox40 + CD25 + CD4 + T cells between each of the chronic Chagas patients groups and the 101 non-infected subjects when cells were stimulated with parasitic antigens (p=0.003 for A 102 vs. NI, p=0.01 for C vs. NI, Figure 1C ). All groups responded significantly to PHA 103 stimulation in comparison with the unstimulated condition ( Figure 1E) . No difference was 104 observed between groups A and C in response to parasite antigens. In addition, the fold 105 change in the frequency of CD4 + Ox40 + CD25 + T cells upon stimulation with T. cruzi 106 antigens, but not with PHA, was greater for both groups of infected patients than for the 107 NI control group (Figure 1F, G) . 108
In conclusion, the AIM method using the marker combination Ox40/CD25 can be used 109 to detect anti-T. cruzi response in CD4 + T cells from chronic Chagas disease patients, 110 upon in vitro stimulation with parasite lysate. 111
Chronic Chagas disease patients have increased frequencies of circulating 112
CD4 + TIGIT + T cells 113
Next, we assessed the expression of the inhibitory receptor TIGIT on circulating CD4 + T 114 cells from Chagas disease patients and control donors. Figure 2A represents the 115 expression profile of this receptor in representative donors from each group. 116
As depicted on Figure 2B and C, the frequency of TIGIT + cells was not affected in each 117 case by stimulation with T. cruzi antigens, nor with PHA. Nonetheless, a striking 118 difference was observed between chronic Chagas disease patients and non-infected 119 individuals. Although statistical significance was not reached when each of the groups 120 were considered separately, the frequency of CD4 + TIGIT + T cells was significantly higher 121 in chronic Chagas disease patients than in the control group subjects upon stimulation 122 with T. cruzi lysate or PHA (p=0.047 and p=0.021 respectively, Figure 2D ). In the 123 unstimulated condition, although there is a visible trend with a low p-value (p=0.059), the 124 difference is, strictly speaking, non-statistically significant. 125
The expression of TIGIT was also analyzed separately within activated (Ox40 + CD25 + ) or 126 non-activated (Ox40or CD25 -) CD4 + T cells. Upon non-specific stimulation with PHA, 127 the frequency of TIGIT-expressing activated CD4 + T cells was significantly reduced 128 (p>0.01) in comparison with the unstimulated and the lysate conditions, but this was not 129 observed for chronic Chagas patients with cardiac manifestation (Figure 2E) . When the 130 non-activated cells were analyzed, only subjects from the chronic Chagas patients 131 groups showed an increased frequency of TIGIT + events upon stimulation with PHA as 132 compared with the non-stimulated condition. No other differences were observed 133 regarding the effect of the stimuli on the cells of each of the groups. 134
Tim-3-expressing CD4 + T cells are more abundant in the circulation of chronic 135
Chagas patients with compromised cardiac function 136
Since Tim-3 is another inhibitory receptor related to T cell exhaustion, we decided to 137 investigate its possible implications for chronic Chagas disease. The frequency of CD4 + 138 T cells expressing Tim-3 was assessed using the same experimental approach 139 described above. The expression profiles for these cells in a representative subject from 140 each group are shown in Figure 3A . 141
The results depicted on Figure 3B revealed that the frequency of CD4 + Tim-3 + T cells 142 were statistically undistinguishable between groups in absence of antigenic stimulation, 143 or upon non-specific stimulation with PHA. However, exposure to T. cruzi lysate unveiled 144 differences in the frequency of such cells, which is higher in subjects from the C group 145 compared to the NI group (p=0.04). In fact, the fold increase in the expression of this 146 receptor is greater for chronic Chagas patients in group C than for the other two groups 147 (Figure 3C) , with the difference being statistically significant only for the comparison 148 between C and NI subjects (p~0.008, medians: 0.91, 1.03 and 1.28 for NI, A and C 149 respectively). This difference was observed separately in both the activated and the non-150 activated subsets upon encounter with parasite antigens (Figure 3D) . 151
Within each group, the abundance of Tim-3 + cells was affected by stimulation with PHA, 152 being significantly higher compared to the non-stimulated and the parasite lysate 153 stimulation conditions, in non-infected subjects and patients from group A, but not in 154 patients from group C (Figure 3D) . Of note, when activated and non-activated CD4 + T 155 cells were analyzed separately, the same difference was observed in the non-activated subset for both the A and NI groups, but the A group showed a statistically significant 157 increase in activated Tim-3 + CD4 + T cells as well (Figure 3E, F) . 158
Lag-3 expression may withdraw CD4+ T cells from activation against T. cruzi 159 antigenic stimulus in chronic Chagas patients without cardiac compromise 160
The third and last inhibitory receptor we looked into in the context of chronic Chagas 161 disease was Lag-3. The expression profile of this receptor under different stimulation 162 conditions is shown for a representative subject in Figure 4A . 163 While no statistically significant differences were found in the frequency of CD4 + Lag-3 + 164 T cells between groups in any of the stimulation conditions, this parameter was 165 significantly affected by stimulation with PHA for subjects from groups A (p=0.005) and 166 NI (p=0.01). The patients in group C showed an increase of these cells, but the difference 167 did not meet the significance cutoff (p=0.054). Interestingly, only patients in group A 168 showed an increase in representation of Lag-3 + cells upon stimulation with parasite 169 lysate (p=0.017), which was also seen as a significantly higher fold change value for this 170 subset upon T. cruzi antigens stimulation, compared to that shown by NI subjects 171 (Figure 4C, p=0.023) . 172
Further subsetting of the CD4 + T cells population according to CD25 and Ox40 revealed, 173 remarkably, that the increase in representation of Lag3-expressing cells observed in 174 group A patients was virtually ascribed to non-activated cells (p=0.003), while no 175 significant change was observed in the frequency of Lag3 + cells within the activated cells 176 gate (p=0.068, Figure 4D, E) . The fold change in size of this population reflects this 177 conclusion (Figure 4F) . 178
Discussion 179
In the light of the clear link between T cell exhaustion and chronic Chagas disease, the 180 expression profile of inhibitory receptors and their implications for anti-parasite response 181 may help shedding light on the pathogenesis of inflammatory disease associated to T. 182 cruzi infection. In this article, we report that TIGIT, Tim-3 and Lag-3 are expressed 183 differently, or they behave in diverging ways upon in vitro stimulation, in chronic Chagas 184 disease patients with different degrees of cardiac compromise. 185
The diversity of response profiles that CD4 + T cells may display in reaction to their 186 cognate epitopes poses an obstacle for the determination of overall activation within this 187 subset. Hence, the discovery of a combination of surface markers, addressable by flow 188 cytometry, that may serve to this purpose 12-14 was a critical development for 189 experimental designs like the one presented herein. Our data showed that in 190 experimental exposure to T. cruzi antigens, the combination of markers Ox40 and CD25 191 clearly signs an activation of CD4 + T cells with memory response characteristics, as it is 192 significantly different in chronic Chagas disease patients than in naïve subjects. 193 TIGIT is an immunomodulatory receptor expressed by T and NK cells, which binds to 194 CD112 and CD155, producing an inhibitory signal that negatively regulates cellular 195 response and IL-12 production from mature dendritic cells while promoting IL-10 196 secretion 11, 20 . In addition, TIGIT + Treg cells have been shown to selectively inhibit Th1 197 and Th17, but not Th2 cells 21 . In HIV infection, it is co-expressed with PD-1, and may be 198 regarded as an indicator of T cell exhaustion and severity of the infection, as TIGIT + 199 CD4 + T cells are more frequent in viral non-controllers than in elite controllers and non-200 infected individuals 22 . Our results indicate that the frequency of circulating CD4 + T cells 201 expressing this surface marker is elevated in chronic Chagas patients from both groups 202 analyzed in this study. It is worth noting that TIGIT expression has been reported to be 203 induced at the event of TCR-signaled activation of CD4 + T cells 23, 24 . In contrast, in our 204 experimental set up, the frequency of CD4 + expressing this marker showed no change 205 upon stimulation with parasite lysate, and a maigre increase with PHA. A tendency is 206 visible in samples from the A group by which the frequency of TIGIT + cells is reduced 207 within the Ox40 + CD25 + subset in the lysate activated condition. This trend, which is 208 evident in the PHA activated condition for all groups, may be associated with a decrease 209 in the representation of Treg cells inside that population in favour of non-regulatory 210 activated T cells. Of note, this was not observed in patients from the C group. 211
In order to interact with its ligand, galectin 9 (Gal-9), Tim-3 has a mucin domain that is 212 highly glycosylated 11,25 . This is of particular interest in the case of chronic Chagas 213 disease, as T. cruzi has been shown to tamper with T cell regulation by altering their 214 surface glycosylation pattern via enzymes of the trans-sialidase superfamily (Marques 215 da Fonseca 2019). Of note, a link between the expression of Gal-9 in myenteric ganglia 216 from chronic Chagas patients and the enteric manifestation of the disease has been 217 proposed 26 . Whether this is also the case in the cardiac forms of chronic Chagas disease, 218 and its possible implications for immune regulation in this pathology via Tim-3 is yet to 219 be investigated. Nonetheless, Lasso et al. 27 described that this receptor is expressed in 220 higher frequencies of CD8 + T cells in chronic Chagas patients than in non-T. cruzi 221 infected donors. Our observations indicate that this difference also applies to CD4 + T 222 cells. In fact, the frequency of Tim-3 + cells within this population increases in chronic 223
Chagas patients but not in non-infected subjects, upon exposure to parasite antigens. In 224 addition, this inhibitory receptor seems to be upregulated in non-activated cells under 225 this condition, despite this difference not being statistically significant.
Lag-3 is a negative regulator of T cell proliferation. It is believed to exert its inhibitory 227 function, not only by competing with the CD4 co-receptor for class II MHC binding in the 228 context of immune synapsis, but also by interacting with proteins from other signaling 229 pathways, like LSECtin 4,11 . Its immune suppressive function has been shown to be 230 subordinated to and synergistic with that of PD-1, and therefore is receiving much 231 attention from the oncotherapy research community 11 . Our results show that, in the 232 context of chronic Chagas disease, the frequency of CD4 + T cells expressing Lag-3 is 233 boosted by polyclonal activation with PHA in all of the evaluated groups of donors, but 234 only in group A upon parasite-specific stimulation. An outstanding outcome of our 235 experiments is that this increased frequency of Lag-3 + cells occurs within the non-236 activated subpopulation. This may implicate that this receptor is preventing pathogen-237 reactive CD4 + T cells from triggering an effector response. Furthermore, as this was not 238 observed in cardiac patients, it is tempting to think on a possible participation of Lag-3 + 239 T cells-mediated modulation of the immune response in preventing inflammatory 240 pathogenesis. At this point, it should be noted that this inhibitory receptor is expressed 241 on natural and induced regulatory T cells 11 . Also, evidence of an increment on the 242 frequency of regulatory T cells induced by in vitro stimulation with T. cruzi antigens has 243 been reported previously 28 . Further analysis of our data will let us determine whether the 244 increase in the frequency of Lag-3 + cells within the so-termed non-activated population 245 occurs within the CD25 + subset, or on the contrary involves CD25lymphocytes only, 246 which would rule out Tregs as accountable for these changes. 247
Another scope to be incorporated in future versions of this report is that of combined 248 expression of multiple inhibitory receptors. As opposed of multifunctionality and in the 249 light of the apparent regulatory hierarchy these receptors take part in 4 , the conjoined 250 expression of different inhibitory receptors may imply different stages of immune 251 modulation, which may point at differences between groups of patients and shed light on 252 processes relevant for the, still elusive, pathogenesis of Chagas associated heart 253 disease. On that direction, work is underway to develop a multiparametric analytic 254 pipeline that enables, not only practical analysis of the combined expression of multiple 255 markers, but also the evaluation of changes in the levels of expression (measured as 256 mean fluorescence intensity of staining) across multiple experiments. 257
Finally, experimental in vitro blockade of these receptors will help us to better understand 258 the implications of the observations resulting from de data presented herein at a 259 functional level. 
